Patient review is important to minimise the number of anticholinergic drugs where possible. Some patients may be suitable for a ‘drug holiday’.
Anticholinergic drugs are prescribed for a wide range of conditions, including Parkinson’s disease,
overactive bladder, COPD, nausea and vomiting, depression and psychosis. Combining treatments with anticholinergic activity might have cumulative harmful effects when given to a person with more than one clinical condition. This potential for harm increases with frailty and age.
Some useful resources are included below:
|Newsletter February 2020||Deprescribing anticholinergics in UI section||Download|
|Anticholinergic Supplement - July 18||Background ; Medication Review ; NICE Dementia Guideline 2018; Examples of drugs with severe anticholinergic effects ; Recommendations to optimise prescribing and improve patient safety ; Antimuscarinics for OAB/UI-Improving Patients Safety||Download|
|Anticholinergic Supplement - Feb 16||Anticholinergic Drugs in Older People||Download|